Solution structure of midkine, a new heparin-binding growth factor

EMBO Journal

Volumn 16, Issue 23, 1997, Pages 6936-6946

  Iwasaki, Wakana ^a,b   Nagata, Koji ^a   Hatanaka, Hideki ^a   Inui, Tatsuya ^c   Kimura, Terutoshi ^c   Muramatsu, Takashi ^d   Yoshida, Keiichi ^e   Tasumi, Mitsuo ^b   Inagaki, Fuyuhiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Peptide Institute Inc   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SEIKAGAKU CORPORATION   (Japan)

Author keywords

Dimerization; Growth factor; Heparin binding; Midkine; Three dimensional structure

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEPARIN; MIDKINE; PLASMINOGEN ACTIVATOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SULFATE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CONSENSUS SEQUENCE; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; ENDOTHELIUM CELL; NERVE FIBER GROWTH; NEURITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; STOICHIOMETRY;

EID: 0030663341     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.23.6936     Document Type: Article

References (59)

1. Adachi, Y. et al. (1996) Midkine as a novel target gene for Wilms tumor suppressor gene (WTI). Oncogene, 13, 2197-2203.
2. Arakawa, T., Wen, J. and Philo, J.S. (1994) Stoichiometry of heparin binding to basic fibrobrast growth factor. Arch. Biochem. Biophys., 308, 267-273.
3. Aridome, K., Tsutsui, J., Takao, S., Kadomatsu, K., Ozawa, M., Aikou, T. and Muramatsu, T. (1995) Increased midkine gene expression in human gastrointestinal cancers. Jap. J. Cancer Res., 118, 88-93.
4. Asai, T., Watanabe, K., Kojima, S., Ichihara-Tanaka, K., Kaneda, N., Iguchi, A., Inagaki, F. and Muramatsu, T. (1997) Heparin binding sites in midkine; identification and analysis of their different roles in neurite guidance and in enhancement of plasminogen activator activity. Biochem. Biophys. Res. Commun., 236, 66-70.
5. Cardin, A.D. and Weintraub, H.J.R. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arterioclerosis, 9, 21-32.
6. Cavanagh, J. and Rance, M. (1992) Suppression of cross-relaxation effects in TOCSY spectra via a modified DISPI-2 mixing sequence. J. Magn. Resonance, 96, 670-678.
7. Chauhan, A.K., Li, Y.S. and Deuel, T.F. (1993) Pleiotrophin transfoms NIH3T3 cells and induces tumors in nude mice. Proc. Natl Acad. Sci. USA, 90, 679-682.
8. Clore, G.M., Brünger, A.T., Karplus, M. and Gronenborn, A.M. (1986) Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. J. Mol. Biol., 191, 523-531
9. Czubayko, F., Schulte, A.M., Berchem, G.J. and Wellstein, A. (1996) Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl Acad. Sci. USA, 93, 14753-14758.
10. Fabri, L., Nice, E.C., Ward, L.D., Maruta, H., Burgess, A.W. and Simpson, R.J. (1992). Characterization of bovine heparin-binding neurotrophic factor (HBNF) - assignment of disulfide bonds. Biochem. Int., 28, 1-9.
11. Fabri, L., Maruta, H., Muramatsu, H., Muramatsu, T., Simpson, R.J., Burgess, AW. and Nice, E.C. (1993) Structural characterization of native and recombinant forms of the neurotrophic cytokine MK. J. Chromatogr., 646, 213-226.
12. Hatanaka, H., Oka, M., Kohda, D., Tate, S., Suda, A., Tamiya, N. and Inagaki, F. (1994) Tertiary structure of erabutoxin b in aqueous solution as elucidated by two-dimensional nuclear magnetic resonance. J. Mol. Biol., 240, 155-166.
13. Inui, T. et al. (1996) Solution synthesis of human midkine, a novel heparin-binding neurotrophic factor consisting of 121 amino acid residues with five disulfide bonds. J. Peptide Sci., 2, 28-39.
14. Jeener, J., Meier, B.H., Bachmann, P. and Ernst, R.R. (1979) Investigation of exchange processes by two-dimesional NMR spectroscopy. J. Chem. Phys., 71, 4546-4553.
15. Kadomatsu, K., Tomomura, M. and Muramatsu, T. (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in midgestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun., 151, 1312-1318.
16. Kadomatsu, K., Huang, R.-P., Suganuma, T., Murata, F. and Muramatsu, T. (1990) A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol., 110, 607-616.
17. Kadomatsu, K., Hagihara, M., Akhter, S., Fan, Q.-W., Muramatsu, H. and Muramatsu, T. (1997) Midkine induces the transformation of NIH3T3 cells. Br. J. Cancer, 75, 354-359.
18. Kaneda, N., Talukder, A.H., Ishihara, M., Hara, S., Yoshida, K. and Muramatsu, T. (1996a) Structural characteristics of heparin-like domain required for interaction of midkine with embryonic neurons. Biochem. Biophys. Res. Commnun., 220, 108-112.
19. Kaneda, N., Talukder, A.H., Nishiyama, H., Koizumi, S. and Muramatsu, T. (1996b) Midkine, a heparin-binding growth/differentiation factor, possesses nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J. Biochem., 119, 1150-1156.
20. Kinnunen, T., Raulo, E., Nolo, R., Maccarana, M., Lindahl, U. and Rauvala, H. (1996) Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J. Biol. Chem., 271, 2243-2248.
21. Kojima, S., Muramatsu, H., Amanuma, H. and Muramatsu, T. (1995a) Midkine enhances fibrinolytic activity of bovine endothelial cells. J. Biol. Chem., 270, 9590-9596.
22. Kojima, S., Inui, T., Kimura, T., Sakakibara, S., Muramatsu, H., Amanuma, H., Maruta, H. and Muramatsu, T. (1995b) Synthetic peptides derived from midkine enhances plasminogen activator in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun., 206, 468-473.
23. Kojima, S., Inui, T., Muramatsu, H., Kimura, T., Sakakibara, S. and Muramatsu, T. (1995c) Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension. Biochem. Biophys. Res. Commun., 216, 574-581.
24. Kojima, S. et al. (1997) Dimerization of midkine by transglutaminase and its functional implication. J. Biol. Chem., 202, 9410-9416.
25. Kurtz, A., Schulte, A.M. and Wellstein, A. (1995) Pleiotrophin and midkine in normal development and tumor biology. Crit. Rev. Oncogen., 6, 151-171.
26. Li, Y.S., Milner, P.G., Chauhan, A.K., Watson, M.A., Hoffman, R.M., Kodner, C.M., Milbrant, J. and Deuel, T.F. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science, 250, 1690-1094.
27. Lindhal, U., Lindholt, K., Spillmann, D. and Kjellen, L. (1991) More to heparin than anticoagulation. Thromb. Res., 75, 1-32.
28. Maccarana, M., Casu, B. and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem., 268, 23898-23905.
29. Macura, S., Huang, Y. Suter, D. and Emst, R.R. (1981) Two-dimensional chemical exchange and cross-relaxation spectroscopy of coupled nuclear spins. J. Magn. Resonance, 43, 259-281.
30. Maeda, N., Nishiwaki, T., Hamanaka, H. and Noda, M. (1996) 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase 5 (RPTPβ) binds pleiotrophin/heparin binding growth associated-molecule (HB-GAM). J. Biol. Chem., 271, 21446-21452.
31. Mahoney, S.-A., Perry, M., Seddon, A., Bohlen, P. and Haynes, L. (1996) Transglutaminase forms midkine homodimers in cerebellar neurons and modulates its neurite-outgrowth response. Biochem. Biophys. Res. Commun., 224, 147-152.
32. Matsuda, Y., Talukder, A.H., Ishihara, M., Hara, S., Yoshida, K., Muramatsu, T. and Kaneda, N. (1996) Limited proteolysis by chymotrypsin of midkine and inhibition by heparin binding. Biochem. Biophys. Res. Commun., 228, 176-181.
33. Matsumoto, K., Wanaka, A., Takatsuji, K., Muramatsu, H., Muramatsu, T. and Tohyama, M. (1994) A novel family of heparin-binding growth factors, pleiotrophin and midkine are expressed in the developing rat cerebral cortex. Dev. Brain Res., 79, 229-241.
34. Merenmies, J. and Rauvala, H. (1990) Molecular cloning of the 18kDa growth-associated protein of developing brain. J. Biol. Chem., 265, 16721-16724.
35. Michikawa, M., Xu, R.Y., Muramatsu, H., Muramatsu, T. and Kim, S.U. (1993a) Midkine is a mediator of retinoic acid induced neuronal differentiation of embryonal carcinoma cells. Biochem. Biophys. Res. Commun., 192, 1312-1318.
36. Michikawa, M., Kikuchi, S., Muramatsu, H., Muramatsu, T. and Kim, S.U. (1993b) Retinoic acid responsive gene product, midkine (MK), has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J. Neurosci. Res., 35, 530-539.
37. Mitsiadis, T.A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M. and Thesleff, I. (1995a) Expression of the heparin-bindins cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organonesis. Development, 121, 37-51.
38. Mitsiadis, T.A., Muramatsu, T., Muramatsu, H. and Thesleff, I. (1995b) Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J. Cell Biol., 129, 267-281.
39. Mulloy, B., Forster, M.J., Jones, C. and Davis, D.B. (1993) N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem. J., 293, 849-858.
40. Muramatsu, H., Shirahama, H., Yonezawa, S., Maruta, H. and Muramatsu, T. (1993) Midkine (MK), a retinoic acid-inducible growth/ differentiation factor: immunochemical evidence for the function and distribution. Dev. Biol., 159, 392-102.
41. Muramatsu, H., Inui, T., Kimura, T., Sakakibara, S., Song, X., Maruta, H. and Muramatsu, Y. (1994) Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. Biochem. Biopys. Res. Commun., 203, 1131-1139.
42. Muramatsu, T. (1994). The midkine family of growth/differentiation factors. Dev. Growth Differ., 36, 1-8.
43. Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T.F., Zhao, H., Cnaan, A. and Brodeur, G.M. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55, 1792-1797.
44. O'Brien, D., Cranston, D., Fuggle, S., Bicknell, R. and Harris, A.L. (1996) The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res., 56, 2515-2518.
45. Peng, H.B., Ali, A.A., Dai, Z., Daggett, D.F., Raulo, E. and Rauvala, H. (1995). The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J. Neurosci., 15, 3027-3038.
46. Rance, M., Sørensen, O.W., Bodenhausen, G., Wagner, G., Ernst, R.R. and Wüthrich, K. (1983) Improved spectral resolution in COSY proton NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun., 117, 479-485.
47. Raulais, D., Lagente-Chevallier, O., Guettet, C., Duprez, D., Courtois, Y. and Vigny, M. (1991) A new heparin-binding protein regulated by retinoic acid from chick embryos. Biochem. Biophys. Res. Commun., 174, 708-715.
48. Raulo, E., Chernousov, M.A., Carey, D.J., Nolo, R. and Rauvala, H. (1994) Isolation of a neural cell surface receptor of heparin binding growth-associated molecule (HB-GAM). J. Biol. Chem., 269, 12999-13004.
49. Rauvala, H. (1989) An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J., 8, 2933-2941.
50. Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulator of growth factor activites. Cell, 64, 867-869.
51. Schulte, A.M., Lai, S., Kartz, A., Czubayko, F., Riegel, A.T. and Wellstein, A. (1996) Human trophoblast and choricarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc. Natl Acad. Sci. USA, 93, 14759-14764.
52. Spivak-Kroizman, T. et al. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell, 79, 1015-1024.
53. Tomomura, M., Kadomatsu, K., Matsubara, S. and Muramatsu, T. (1990) A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J. Biol. Chem., 265, 10765-10770.
54. Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y. and Muramatsu, T. (1993) A new family of heparin-binding growth differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res., 53, 1281-1285.
55. Unoki, K., Ohba, N., Arimura, H., Muramatsu, H. and Muramatsu, T. (1994) Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid responsive gene product. Invest. Ophthalmol. Vis. Sci., 35, 4063-4068.
56. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. and Ornitz, D.M. (1991) Cell surface heparin-like molecules are required for binding of bFGF to its high affinity receptor. Cell, 64, 841-848.
57. Yoshida, Y., Goto, M., Tsutsui, J., Ozawa, M., Sato, E., Osame, M. and Muramatsu, T. (1995) Midkine is present in the early stage of cerebral infarct. Dev. Brain Res., 85, 25-30.
58. Wagner, G., Braun, W., Havel, T.F., Schaumann, T., Go, N. and Wüthrich, K. (1987) Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms. DISGEO and DISMAN. J. Mol. Biol., 196, 611-639.
59. Wüthrich, K. (1986) N.M.R. of Proteins and Nucleic Acids. John Wiley and Sons, New York.